Viewing Study NCT00544960

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:02 AM
Ignite Modification Date: 2026-02-25 @ 7:05 PM
Study NCT ID: NCT00544960
Status: COMPLETED
Last Update Posted: 2010-08-27
First Post: 2007-10-12
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Sponsor: Ascenta Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None AT101 View
None AT-101 View
None cancer View
None lung View
None non-small cell View
None docetaxel View
None bcl View